Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 4,370 shares at $49.52 ($217K) on 2021-08-19, disclosed to the SEC on 2021-08-23.
Open-market sale of $217k DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.52 | 2,085 | $103K | 47.7% |
| 2 | $49.52 | 2,085 | $103K | 47.7% |
| 3 | $50.07 | 200 | $10K | 4.6% |
| Total | $49.55 avg | 4,370 | $217K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |